Brandon Price

Brandon Price discloses dealings in CanniMed Therapeutics Inc. to SEDI. We count 3 filings; the first trade dates from 1 November 2016 and the latest from 8 February 2018.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The latest filing, published on 9 February 2018, reports an option exercise of €7,856 in CanniMed Therapeutics Inc. Between a trade and the moment it shows up on SEDI, the median delay is 1 day. The shorter that gap, the sooner other investors can see what insiders have done. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.